Kratom can cause euphoria, particularly at moderate to high doses. The effect comes from alkaloids in the kratom leaf that bind to the same brain receptors as opioid drugs like morphine and codeine. The intensity varies widely depending on the dose, the specific product, and individual factors, but euphoria is one of the most commonly reported reasons people use kratom.
How Kratom Produces Euphoria
Kratom leaves contain more than 50 alkaloids, but two do most of the heavy lifting: mitragynine and 7-hydroxymitragynine. Both bind to mu-opioid receptors, the same targets that morphine, codeine, and fentanyl act on. When these receptors are activated, the brain releases dopamine in reward circuits, producing feelings of pleasure, warmth, and well-being.
Mitragynine is the most abundant alkaloid in kratom, making up roughly 1 to 2% of dried leaf weight. Its binding affinity for mu-opioid receptors is about 89 times weaker than morphine’s, which is why kratom’s euphoric effects are generally milder than those of prescription opioids. The second alkaloid, 7-hydroxymitragynine, is far more potent, roughly 13 times stronger than morphine at the receptor level. However, it exists in very small amounts in natural kratom leaf, typically less than 0.05% by weight, with one large analysis of 341 samples finding an average of just 0.01%.
These alkaloids are sometimes called “atypical opioids” because they activate opioid receptors through a slightly different signaling pathway than traditional opioids. They trigger the initial G-protein signaling that produces pain relief and euphoria but are less likely to activate a secondary pathway (called beta-arrestin recruitment) that is responsible for many classic opioid side effects like respiratory depression and heavy sedation. This difference helps explain why kratom’s euphoria feels less intense and carries a somewhat lower overdose risk than heroin or fentanyl, though it is not risk-free.
Dose Makes the Difference
Kratom’s effects shift dramatically depending on how much you take. At low doses, between 1 and 5 grams of dried leaf, kratom acts more like a stimulant. Users report increased energy, alertness, and sociability, with mild mood elevation but not pronounced euphoria. This is the dose range traditionally used by laborers in Southeast Asia to fight fatigue during long workdays.
At higher doses, roughly 5 to 15 grams, the opioid-like effects take over. This is where euphoria becomes more prominent, along with pain relief, relaxation, and sedation. The higher you go within this range, the more the experience resembles a traditional opioid high, complete with a warm, drowsy contentment that users sometimes describe as an “opioid buzz.” Doses above 15 grams significantly increase the risk of nausea, sedation, and other adverse effects.
How Long the Effects Last
The timeline depends on how you consume kratom. Chewing fresh leaves produces the fastest onset, with effects appearing within 5 to 10 minutes and euphoria lasting up to about an hour. Drinking kratom tea or a liquid extract on an empty stomach brings on effects within 10 to 20 minutes. Swallowing capsules on a full stomach can delay onset by 1 to 3 hours.
The stimulating phase typically lasts 1 to 2 hours, while the sedating and euphoric effects can persist for an additional 1 to 3 hours. Total duration of action runs between 2 and 7 hours. Some users report lingering aftereffects, like mild relaxation or grogginess, that stretch into the next day. Mitragynine has an estimated half-life of about 3 hours, meaning half of it is cleared from your system in that time, though it can take several half-lives before the substance is fully eliminated.
Kratom Euphoria vs. Traditional Opioids
People who have experience with both kratom and prescription opioids generally describe kratom’s euphoria as milder and more functional. You’re less likely to feel the heavy, nodding-off sedation that comes with drugs like oxycodone or heroin, partly because of the different signaling pathway mentioned earlier. Kratom also retains stimulant properties at lower doses that traditional opioids simply don’t have.
That said, the gap narrows with concentrated products. Some commercial kratom products are now enriched with synthetic or extracted 7-hydroxymitragynine, pushing concentrations well above what occurs naturally in the leaf. The FDA has flagged these products specifically, noting that users on social media describe euphoria and an opioid-like high as a primary motivation for consuming them. These concentrated formulations carry a meaningfully higher risk of dependence, withdrawal, and overdose compared to plain leaf kratom.
Risks That Come With the High
The same receptor activity that produces euphoria also creates the potential for dependence. With regular use, your brain’s opioid receptors adapt, requiring higher doses to achieve the same effect. Stopping abruptly can trigger withdrawal symptoms that mirror opioid withdrawal: muscle aches, irritability, insomnia, nausea, and anxiety. The timeline and severity are generally less intense than withdrawal from drugs like heroin, but they are real and can be quite uncomfortable.
The FDA warns that kratom use carries risks including liver toxicity, seizures, and substance use disorder. Kratom is not approved as a drug, dietary supplement, or food additive in the United States. There are no standardized doses, and because kratom products are unregulated, alkaloid concentrations can vary enormously from one batch to the next. A dose that produced mild stimulation from one vendor might produce strong sedation and euphoria from another.
Combining kratom with other substances increases danger considerably. Mixing it with alcohol, benzodiazepines, or other opioids can amplify sedation and respiratory depression. Most kratom-associated deaths reported in the medical literature involve polydrug use rather than kratom alone, but the risk is not zero even with kratom by itself, especially with high-potency extracts.